ASPCF - Acerus Pharmaceuticals GAAP EPS of $0.00 revenue of $0.78M May, 10 2022 07:56 AM Acerus Pharmaceuticals Corp Acerus Pharmaceuticals press release (OTCQB:ASPCF): Q1 GAAP EPS of $0.00. Revenue of $0.78M (+239.1% Y/Y). For further details see: Acerus Pharmaceuticals GAAP EPS of $0.00, revenue of $0.78M